Related Experiment Video
Updated: Feb 1, 2026

Isolation of Salivary Epithelial Cells from Human Salivary Glands for In Vitro Growth as Salispheres or Monolayers
Published on: July 15, 2019
Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic
Liang Xia1,2, Yang Wang1, Yuhua Hu1
1Department of Oral Pathology, Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People's Republic of China, tian0304_cn@163.com.
Background:
To inhibit human epithelial growth factor receptor 2 (HER2) in salivary carcinoma ex pleomorphic adenoma (CXPA) and investigate the effects on tumor cell proliferation, cell cycle, and apoptosis. To assess the possibility of blocking HER2 to improve the malignant biological behavior of CXPA.
Materials And Methods:
HER2 expression and amplification were examined using an immunofluorescence assay and fluorescence in situ hybridization in 2 CXPA cell lines (SM-AP1 and SM-AP4 cells). The effects on tumor cell proliferation, cell cycle, apoptosis, and HER2 downstream pathways were verified after the application of a HER2 inhibitor.
Results:
HER2 was overexpressed and amplified in SM-AP1 and SM-AP4 cell lines. After blocking HER2, the tumor proliferation and cell cycle were significantly induced, and the apoptosis process was activated. Moreover, the downstream pathways PI3K/AKT and MAPK/ERK were significantly inhibited.
Conclusion:
HER2 was overexpressed and amplified in CXPA cell lines and might thus play an important role in tumor development. Inhibiting HER2 may be a novel targeted therapy for poor biological behavior of CXPA.
Insights
Inhibiting human epithelial growth factor receptor 2 (HER2) in salivary carcinoma ex pleomorphic adenoma (CXPA) significantly reduced tumor proliferation and activated apoptosis. This suggests HER2 inhibition as a potential targeted therapy for aggressive CXPA.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Salivary carcinoma ex pleomorphic adenoma (CXPA) is a malignancy with potential for aggressive behavior.
- Human epithelial growth factor receptor 2 (HER2) is implicated in various cancers and may play a role in CXPA progression.
Purpose of the Study:
- To investigate the role of HER2 in CXPA.
- To evaluate the therapeutic potential of HER2 inhibition in CXPA cell lines.
Main Methods:
- HER2 expression and amplification were assessed in CXPA cell lines (SM-AP1, SM-AP4) using immunofluorescence and fluorescence in situ hybridization.
- The effects of a HER2 inhibitor on cell proliferation, cell cycle, apoptosis, and downstream signaling pathways (PI3K/AKT, MAPK/ERK) were analyzed.
Main Results:
- HER2 was found to be overexpressed and amplified in the studied CXPA cell lines.
- HER2 inhibition led to significant induction of tumor cell proliferation and cell cycle progression.
- Apoptosis was activated, and downstream signaling pathways PI3K/AKT and MAPK/ERK were significantly inhibited following HER2 blockade.
Conclusions:
- Overexpression and amplification of HER2 in CXPA suggest its involvement in tumor development.
- Targeting HER2 represents a promising novel therapeutic strategy for managing the aggressive biological behavior of CXPA.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: Osmolarity
Biodiversity and Human Values